Market Cap
$1.1B
BVS
Bioventus Inc.
$13.13 ▼ -2.38%
Prev close $13.45Market cap$1.1B
ConsensusStrong Buy
12-mo target$17.60 (+34.0%)
▲ Bullish
Analyst conviction 9/10
High Impact Filing (7/10)25 New Institutional Positions9 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on BVS right now — valuation, ownership and activity at a glance.
Cap Size
Small Cap
Analyst Consensus
Strong Buy (89%)
Inst. Holders
50 funds
Inst. Value
$205.0M
Inst. Activity
25 buys / 9 sells
Insider Activity
$0.00 buy / $105.4K sell
Insider Net $
-$105.4K
SEC Reports
12
Press Releases
1
Price chart 30d -8.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 9, 2026 ftd
Aug 15, 2026 SEC FTD: BVS — 44,637 shares ($0.6M) failed to deliver
Settlement: 20260909, Price: $13.83, FTD Value: $617,329.71, BIOVENTUS INC CL A
A mixed institutional cluster formed in BVS during Q2 2026, with 9 buyers accumulating $12.9M in net new positions (domi
INST-CLUSTER — Impact 5/10
Bioventus reported Q2 2026 revenue of $153.2M (+4% YoY), slightly below the $155.6M consensus, and Non-GAAP EPS of $0.22
PRESS-RELEASE — Impact 7/10
Bioventus reported Q2 2026 revenue of $153.2M (+4% YoY), slightly below consensus of $155.6M, and Non-GAAP EPS of $0.22,
8-K — Impact 7/10
Jun 30, 2026 Inst.
AMERICAN CENTURY COMPANIES INC — DOUBLED
1,353,415 shares ($12.8M)
Jun 30, 2026 Inst.
DIMENSIONAL FUND ADVISORS LP — ADD
1,128,465 shares ($10.7M)
Jun 3, 2026 Insider
NEELS GUIDO J was granted 25,146 shares
Director
Jun 3, 2026 Insider
Beyer Pat was granted 25,146 shares
Director
Analyst ratings buy % +3.5%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
89% rate it Buy or better · 9 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Aug 17, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| Aug 17, 2026 | Cantor Fitzgerald | REITERATE | Overweight | 49% |
| Jun 30, 2026 | Barrington Research | MAINTAIN | Outperform | 55% |
| Jun 16, 2026 | Canaccord Genuity | MAINTAIN | Buy | 47% |
| May 22, 2026 | Barrington Research | MAINTAIN | Outperform | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Aug 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Jul 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Jun 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| May 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Apr 1, 2026 | 2 | 6 | 1 | 0 | 0 | 89% | |
| Mar 1, 2026 | 2 | 5 | 1 | 0 | 0 | 88% | |
| Feb 1, 2026 | 1 | 5 | 1 | 0 | 0 | 86% |
Price targets
Where 5 covering analysts think BVS trades over the next 12 months.
$17.60 +34.0% upside Strong Buy
Current$13.13 Low$15.00 Median$18.00 High$19.00 5 analysts
$15.00$19.00
Analyst rating None as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
12 SEC filing reports analyzed · 6 bullish, 2 bearish, 1 mixed, 3 neutral · avg impact 5.3/10.Plus 1 press releases.
MIXEDINST-CLUSTER5/10
A mixed institutional cluster formed in BVS during Q2 2026, with 9 buyers accumulating $12.9M in net
Aug 15, 2026
BULLISHPRESS-RELEASE7/10
Bioventus reported Q2 2026 revenue of $153.2M (+4% YoY), slightly below the $155.6M consensus, and N
Aug 5, 2026
BULLISH8-K7/10
Bioventus reported Q2 2026 revenue of $153.2M (+4% YoY), slightly below consensus of $155.6M, and No
Aug 5, 2026
BEARISHINST-CLUSTER4/10
Three institutional sellers outnumber one buyer in Bioventus during Q3 2025, with a net reduction of
Jun 11, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 9, 2026
ftd
FTD: BVS — 44,637 shares ($0.6M) failed to deliver
Settlement: 20260909, Price: $13.83, FTD Value: $617,329.71, BIOVENTUS INC CL A
Sep 3, 2026
ftd
FTD: BVS — 48,023 shares ($0.7M) failed to deliver
Settlement: 20260903, Price: $14.37, FTD Value: $690,090.51, BIOVENTUS INC CL A
Aug 6, 2026
short_volume
Short Volume: BVS — 70.0% short (0.5M / 0.7M)
Short: 474,112 | Exempt: 8,499 | TRF Vol: 677,033 | Short Ratio: 70.0% | Off-exchange volume (dark pool + OTC)
Aug 5, 2026
earnings
Bioventus Reports Second Quarter Financial Results
DURHAM, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active
Aug 5, 2026
earnings_calendar
BVS Q2 2026 Earnings Scheduled — 2026-08-05
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.16 | $0.13–$0.18 | 6.7% | -9.1% | 0↑ 3↓ | $0.1B | 5 |
| Next Q | $0.25 | $0.23–$0.28 | 4.2% | +4.2% | 2↑ 2↓ | $0.2B | 5 |
| Current FY | $0.78 | $0.77–$0.79 | 14.4% | -0.3% | 0↑ 1↓ | $0.6B | 5 |
| Next FY | $0.92 | $0.88–$0.96 | 18.3% | +1.3% | 1↑ 2↓ | $0.6B | 5 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.160 | — |
| 7d ago | $0.170 | -0.010 |
| 30d ago | $0.176 | -0.016 |
| 60d ago | $0.176 | -0.016 |
| 90d ago | $0.176 | -0.016 |
Institutional ownership
Which big funds own BVS (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $205.0M total value (21,714,385 shares) as of 2026-Q2. Top holders: BlackRock,, ROYCE, VANGUARD. Net buying activity: 25 institutions added/increased vs 9 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 3,435,914 | $32.4M | 15.8% | — |
| ROYCE & ASSOCIATES LP | 1,833,212 | $17.3M | 8.4% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,751,678 | $16.5M | 8.1% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 1,365,716 | $12.9M | 6.3% | — |
| AMERICAN CENTURY COMPANIES INC | 1,353,415 | $12.8M | 6.2% | DOUBLED +118.4% |
| DIMENSIONAL FUND ADVISORS LP | 1,128,465 | $10.7M | 5.2% | ADD +29.2% |
| STATE STREET CORP | 1,104,878 | $10.4M | 5.1% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,042,796 | $9.8M | 4.8% | — |
| WELLINGTON MANAGEMENT GROUP LLP | 748,358 | $7.1M | 3.4% | DOUBLED +385.5% |
| RENAISSANCE TECHNOLOGIES LLC | 736,000 | $6.9M | 3.4% | ADD +50.4% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| AMERICAN CENTURY COMPANIES INC | DOUBLED | 619,803 | 1,353,415 | +118.4% | $12.8M |
| DIMENSIONAL FUND ADVISORS LP | ADD | 873,138 | 1,128,465 | +29.2% | $10.7M |
| WELLINGTON MANAGEMENT GROUP LLP | DOUBLED | 154,141 | 748,358 | +385.5% | $7.1M |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 489,460 | 736,000 | +50.4% | $6.9M |
| GOLDMAN SACHS GROUP INC | ADD | 473,384 | 652,367 | +37.8% | $6.2M |
| PRUDENTIAL FINANCIAL INC | DOUBLED | 193,800 | 394,520 | +103.6% | $3.7M |
| MILLENNIUM MANAGEMENT LLC | DOUBLED | 16,633 | 203,512 | +1123.5% | $1.9M |
| MORGAN STANLEY | TRIM | 258,801 | 193,734 | -25.1% | $1.8M |
| JPMORGAN CHASE & CO | ADD | 98,495 | 149,615 | +51.9% | $1.5M |
| Quantinno Capital Management LP | ADD | 72,023 | 137,515 | +90.9% | $1.3M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
14 insiders, 50 transactions. Net -$105.4K — $0.00 bought, $105.4K sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | NEELS GUIDO J | Director | AWARD | 25,146 | — | — |
| Jun 3, 2026 | Beyer Pat | Director | AWARD | 25,146 | — | — |
| Jun 3, 2026 | Ladone Mary Kay | Director | AWARD | 25,146 | — | — |
| Jun 3, 2026 | HAWKINS WILLIAM A | Director | AWARD | 30,994 | — | — |
| Jun 3, 2026 | Cowdy Philip G. | Director | AWARD | 25,146 | — | — |
| Jun 3, 2026 | STALNECKER SUSAN M | Director | AWARD | 25,146 | — | — |
| Jun 3, 2026 | McMurry-Heath Michelle | Director | AWARD | 25,146 | — | — |
| Jun 3, 2026 | SUTTER MARTIN P | Director | AWARD | 25,146 | — | — |
| Jun 3, 2026 | NOHRA GUY P | Director | AWARD | 25,146 | — | — |
| Jun 3, 2026 | Bartholdson John A. | Director | AWARD | 25,146 | — | — |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for BVS.
Shares short
2,930,690
Settlement Sep 15, 2026
Change vs prior
+13.6%
Semi-monthly cycle
Days to cover
5.7
At avg daily volume
Of shares outstanding
≈3.5%
Estimate — not % of float
All BVS filing & press-release reports (13)
- INST-CLUSTER reportAug 15, 2026
- PRESS-RELEASE reportAug 5, 2026
- 8-K reportAug 5, 2026
- INST-CLUSTER reportJun 11, 2026
- PRESS-RELEASE reportJun 2, 2026
- 8-K reportMay 21, 2026
- COURT-RULING reportMay 9, 2026
- 8-K reportMay 6, 2026
- PRESS-RELEASE reportMay 6, 2026
- PRESS-RELEASE reportApr 28, 2026
- DEFA14A reportApr 22, 2026
- 8-K reportMar 5, 2026
- PRESS-RELEASE reportMar 5, 2026